286 related articles for article (PubMed ID: 18045726)
21. Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate.
Takeuchi T; Kosuge M; Tadokoro A; Sugiura Y; Nishi M; Kawata M; Sakai N; Matile S; Futaki S
ACS Chem Biol; 2006 Jun; 1(5):299-303. PubMed ID: 17163758
[TBL] [Abstract][Full Text] [Related]
22. Cell-penetrating peptides in drug development: enabling intracellular targets.
Chen L; Harrison SD
Biochem Soc Trans; 2007 Aug; 35(Pt 4):821-5. PubMed ID: 17635156
[TBL] [Abstract][Full Text] [Related]
23. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
Meade BR; Dowdy SF
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
[TBL] [Abstract][Full Text] [Related]
24. Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs.
Nguyen J; Xie X; Neu M; Dumitrascu R; Reul R; Sitterberg J; Bakowsky U; Schermuly R; Fink L; Schmehl T; Gessler T; Seeger W; Kissel T
J Gene Med; 2008 Nov; 10(11):1236-46. PubMed ID: 18780309
[TBL] [Abstract][Full Text] [Related]
25. Oral biodrug delivery using cell-penetrating peptide.
Khafagy el-S; Morishita M
Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
[TBL] [Abstract][Full Text] [Related]
26. Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling.
Kilk K; Mahlapuu R; Soomets U; Langel U
Toxicology; 2009 Nov; 265(3):87-95. PubMed ID: 19799958
[TBL] [Abstract][Full Text] [Related]
27. Protein delivery by the cell-penetrating peptide YTA2.
Myrberg H; Lindgren M; Langel U
Bioconjug Chem; 2007; 18(1):170-4. PubMed ID: 17226970
[TBL] [Abstract][Full Text] [Related]
28. Intrinsically cell-permeable miniature proteins based on a minimal cationic PPII motif.
Daniels DS; Schepartz A
J Am Chem Soc; 2007 Nov; 129(47):14578-9. PubMed ID: 17983240
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of cell-penetrating peptides for cargo delivery.
Pooga M; Langel U
Methods Mol Biol; 2005; 298():77-89. PubMed ID: 16044541
[TBL] [Abstract][Full Text] [Related]
30. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
[TBL] [Abstract][Full Text] [Related]
31. Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001-2006.
Fischer PM
Med Res Rev; 2007 Nov; 27(6):755-95. PubMed ID: 17019680
[TBL] [Abstract][Full Text] [Related]
32. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
Endoh T; Ohtsuki T
Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
[TBL] [Abstract][Full Text] [Related]
33. [Potential of cell penetrating peptides for cell drug delivery].
Poillot C; De Waard M
Med Sci (Paris); 2011 May; 27(5):527-34. PubMed ID: 21609675
[TBL] [Abstract][Full Text] [Related]
34. Interactions of amphipathic carrier peptides with membrane components in relation with their ability to deliver therapeutics.
Deshayes S; Morris MC; Divita G; Heitz F
J Pept Sci; 2006 Dec; 12(12):758-65. PubMed ID: 17131287
[TBL] [Abstract][Full Text] [Related]
35. Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.
Ziegler A
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):580-97. PubMed ID: 18045730
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in cell-penetrating, non-peptide molecular carriers.
Chung SK; Maiti KK; Lee WS
Int J Pharm; 2008 Apr; 354(1-2):16-22. PubMed ID: 17890027
[TBL] [Abstract][Full Text] [Related]
37. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides.
Nakase I; Takeuchi T; Tanaka G; Futaki S
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):598-607. PubMed ID: 18045727
[TBL] [Abstract][Full Text] [Related]
38. Studying the uptake of cell-penetrating peptides.
Holm T; Johansson H; Lundberg P; Pooga M; Lindgren M; Langel U
Nat Protoc; 2006; 1(2):1001-5. PubMed ID: 17406337
[TBL] [Abstract][Full Text] [Related]
39. Chemically modified cell-penetrating peptides for the delivery of nucleic acids.
Mäe M; Andaloussi SE; Lehto T; Langel U
Expert Opin Drug Deliv; 2009 Nov; 6(11):1195-205. PubMed ID: 19831582
[TBL] [Abstract][Full Text] [Related]
40. The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides.
Hodoniczky J; Sims CG; Best WM; Bentel JM; Wilce JA
Biopolymers; 2008; 90(5):595-603. PubMed ID: 18351583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]